Japanese cancer association meeting UICC international session - what is cost-effectiveness in cancer treatment?

Hideyuki Akaza, Norie Kawahara, Jae Kyung Roh, Hajime Inoue, Eun Cheol Park, Kwang Sig Lee, Sukyeong Kim, Jasdeep Hayre, Bhash Naidoo, Thomas Wilkinson, Takashi Fukuda, Woo Ick Jang, Masafumi Nogimori

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The Japan National Committee for the Union for International Cancer Control (UICC) and UICC-Asia Regional Office (ARO) organized an international session as part of the official program of the 72nd Annual Meeting of the Japanese Cancer Association to discuss the topic "What is cost-effectiveness in cancer treatment?" Healthcare economics are an international concern and a key issue for the UICC. The presenters and participants discussed the question of how limited medical resources can be best used to support life, which is a question that applies to both developing and industrialized countries, given that cancer treatment is putting medical systems under increasing strain. The emergence of advanced yet hugely expensive drugs has prompted discussion on methodologies for Health Technology Assessment (HTA) that seek to quantify cost and effect. The session benefited from the participation of various stakeholders, including representatives of industry, government and academia and three speakers from the Republic of Korea, an Asian country where discussion on HTA methodologies is already advanced. In addition, the session was joined by a representative of National Institute for Health and Care Excellence (NICE) of the United Kingdom, which has pioneered the concept of cost-effectiveness in a medical context. The aim of the session was to advance and deepen understanding of the issue of cost-effectiveness as viewed from medical care systems in different regions.

Original languageEnglish
Pages (from-to)3-10
Number of pages8
JournalAsian Pacific Journal of Cancer Prevention
Volume15
Issue number1
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Cost-Benefit Analysis
Biomedical Technology Assessment
Neoplasms
Delivery of Health Care
Republic of Korea
National Institutes of Health (U.S.)
Developed Countries
Developing Countries
Industry
Japan
Economics
Costs and Cost Analysis
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Cite this

Akaza, Hideyuki ; Kawahara, Norie ; Roh, Jae Kyung ; Inoue, Hajime ; Park, Eun Cheol ; Lee, Kwang Sig ; Kim, Sukyeong ; Hayre, Jasdeep ; Naidoo, Bhash ; Wilkinson, Thomas ; Fukuda, Takashi ; Jang, Woo Ick ; Nogimori, Masafumi. / Japanese cancer association meeting UICC international session - what is cost-effectiveness in cancer treatment?. In: Asian Pacific Journal of Cancer Prevention. 2014 ; Vol. 15, No. 1. pp. 3-10.
@article{97af069169754d55a5594dfd819073ba,
title = "Japanese cancer association meeting UICC international session - what is cost-effectiveness in cancer treatment?",
abstract = "The Japan National Committee for the Union for International Cancer Control (UICC) and UICC-Asia Regional Office (ARO) organized an international session as part of the official program of the 72nd Annual Meeting of the Japanese Cancer Association to discuss the topic {"}What is cost-effectiveness in cancer treatment?{"} Healthcare economics are an international concern and a key issue for the UICC. The presenters and participants discussed the question of how limited medical resources can be best used to support life, which is a question that applies to both developing and industrialized countries, given that cancer treatment is putting medical systems under increasing strain. The emergence of advanced yet hugely expensive drugs has prompted discussion on methodologies for Health Technology Assessment (HTA) that seek to quantify cost and effect. The session benefited from the participation of various stakeholders, including representatives of industry, government and academia and three speakers from the Republic of Korea, an Asian country where discussion on HTA methodologies is already advanced. In addition, the session was joined by a representative of National Institute for Health and Care Excellence (NICE) of the United Kingdom, which has pioneered the concept of cost-effectiveness in a medical context. The aim of the session was to advance and deepen understanding of the issue of cost-effectiveness as viewed from medical care systems in different regions.",
author = "Hideyuki Akaza and Norie Kawahara and Roh, {Jae Kyung} and Hajime Inoue and Park, {Eun Cheol} and Lee, {Kwang Sig} and Sukyeong Kim and Jasdeep Hayre and Bhash Naidoo and Thomas Wilkinson and Takashi Fukuda and Jang, {Woo Ick} and Masafumi Nogimori",
year = "2014",
month = "1",
day = "1",
doi = "10.7314/APJCP.2014.15.1.3",
language = "English",
volume = "15",
pages = "3--10",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "1",

}

Akaza, H, Kawahara, N, Roh, JK, Inoue, H, Park, EC, Lee, KS, Kim, S, Hayre, J, Naidoo, B, Wilkinson, T, Fukuda, T, Jang, WI & Nogimori, M 2014, 'Japanese cancer association meeting UICC international session - what is cost-effectiveness in cancer treatment?', Asian Pacific Journal of Cancer Prevention, vol. 15, no. 1, pp. 3-10. https://doi.org/10.7314/APJCP.2014.15.1.3

Japanese cancer association meeting UICC international session - what is cost-effectiveness in cancer treatment? / Akaza, Hideyuki; Kawahara, Norie; Roh, Jae Kyung; Inoue, Hajime; Park, Eun Cheol; Lee, Kwang Sig; Kim, Sukyeong; Hayre, Jasdeep; Naidoo, Bhash; Wilkinson, Thomas; Fukuda, Takashi; Jang, Woo Ick; Nogimori, Masafumi.

In: Asian Pacific Journal of Cancer Prevention, Vol. 15, No. 1, 01.01.2014, p. 3-10.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Japanese cancer association meeting UICC international session - what is cost-effectiveness in cancer treatment?

AU - Akaza, Hideyuki

AU - Kawahara, Norie

AU - Roh, Jae Kyung

AU - Inoue, Hajime

AU - Park, Eun Cheol

AU - Lee, Kwang Sig

AU - Kim, Sukyeong

AU - Hayre, Jasdeep

AU - Naidoo, Bhash

AU - Wilkinson, Thomas

AU - Fukuda, Takashi

AU - Jang, Woo Ick

AU - Nogimori, Masafumi

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The Japan National Committee for the Union for International Cancer Control (UICC) and UICC-Asia Regional Office (ARO) organized an international session as part of the official program of the 72nd Annual Meeting of the Japanese Cancer Association to discuss the topic "What is cost-effectiveness in cancer treatment?" Healthcare economics are an international concern and a key issue for the UICC. The presenters and participants discussed the question of how limited medical resources can be best used to support life, which is a question that applies to both developing and industrialized countries, given that cancer treatment is putting medical systems under increasing strain. The emergence of advanced yet hugely expensive drugs has prompted discussion on methodologies for Health Technology Assessment (HTA) that seek to quantify cost and effect. The session benefited from the participation of various stakeholders, including representatives of industry, government and academia and three speakers from the Republic of Korea, an Asian country where discussion on HTA methodologies is already advanced. In addition, the session was joined by a representative of National Institute for Health and Care Excellence (NICE) of the United Kingdom, which has pioneered the concept of cost-effectiveness in a medical context. The aim of the session was to advance and deepen understanding of the issue of cost-effectiveness as viewed from medical care systems in different regions.

AB - The Japan National Committee for the Union for International Cancer Control (UICC) and UICC-Asia Regional Office (ARO) organized an international session as part of the official program of the 72nd Annual Meeting of the Japanese Cancer Association to discuss the topic "What is cost-effectiveness in cancer treatment?" Healthcare economics are an international concern and a key issue for the UICC. The presenters and participants discussed the question of how limited medical resources can be best used to support life, which is a question that applies to both developing and industrialized countries, given that cancer treatment is putting medical systems under increasing strain. The emergence of advanced yet hugely expensive drugs has prompted discussion on methodologies for Health Technology Assessment (HTA) that seek to quantify cost and effect. The session benefited from the participation of various stakeholders, including representatives of industry, government and academia and three speakers from the Republic of Korea, an Asian country where discussion on HTA methodologies is already advanced. In addition, the session was joined by a representative of National Institute for Health and Care Excellence (NICE) of the United Kingdom, which has pioneered the concept of cost-effectiveness in a medical context. The aim of the session was to advance and deepen understanding of the issue of cost-effectiveness as viewed from medical care systems in different regions.

UR - http://www.scopus.com/inward/record.url?scp=84894029029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894029029&partnerID=8YFLogxK

U2 - 10.7314/APJCP.2014.15.1.3

DO - 10.7314/APJCP.2014.15.1.3

M3 - Article

C2 - 24528045

AN - SCOPUS:84894029029

VL - 15

SP - 3

EP - 10

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 1

ER -